Crossmark

Japanese Subgroup Analyses from EMERGE and ENGAGE, Phase 3 Clinical Trials of Aducanumab in Patients with Early Alzheimer's Disease

Crossref DOI link: https://doi.org/10.14283/jpad.2024.106

Published Print: 2024-10

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Toda, Yasuo https://orcid.org/0000-0002-8737-5256
Iwatsubo, T.

Nakamura, Y.

Matsuda, N.

Miyata, M.

Jin, M.

Chen, T.

Kuribayashi, K.

Tian, Y.

Hughes, R.

Yamamoto, J.

Muralidharan, K.K.

Rubel, C.

Hutchison, R.M.

Haeberlein, S. Budd
License Information

Text and Data Mining valid from 2024-10-01

Text and Data Mining valid from 2024-10-01

Version of Record valid from 2024-07-27
More Information

This article is maintained by: Elsevier

Article Title: Japanese Subgroup Analyses from EMERGE and ENGAGE, Phase 3 Clinical Trials of Aducanumab in Patients with Early Alzheimer's Disease

Journal Title: The Journal of Prevention of Alzheimer's Disease

CrossRef DOI link to publisher maintained version: https://doi.org/10.14283/jpad.2024.106

Content Type: article

Copyright: Copyright © 2024 THE AUTHORS. Published by Elsevier Masson SAS on behalf of SERDI Publisher. Published by Elsevier Masson SAS